Due to the unprecedented demand on our Infoline and Ask The Nurse services, we have added additional staff to support you.
Please continue to contact us and visit our dedicated COVID-19 Information Hub for the latest information on how measures may apply to you.

Histone deacetylatse (HDAC) inhibitors

Histone deacetlyase inhibitors are a new type of myeloma treatment currently in clinical trial. Dr Charlotte Pawlyn explains how these inhibitors work and how they are likely to be given to patients.

Related Videos